These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8587511)

  • 1. [The biochemical aspects of the pathogenicity of the causative agent of plague].
    Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
    Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.
    Welkos SL; Davis KM; Pitt LM; Worsham PL; Freidlander AM
    Contrib Microbiol Immunol; 1995; 13():299-305. PubMed ID: 8833858
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 6. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of Pasteurella pestis at 37 degrees C in relation to its antigenic characteristics.
    Gadgil SM; Nimbkar YS; Jhala HI
    Indian J Pathol Bacteriol; 1970 Oct; 13(4):142-52. PubMed ID: 5522253
    [No Abstract]   [Full Text] [Related]  

  • 8. [A method for the accelerated determination of the virulence of Y. pestis cultures in the epizootiological examination of natural plague foci].
    Orlov GS
    Voen Med Zh; 1993 Feb; (2):39-41, 80. PubMed ID: 8498023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some features of action of "murine" toxin and Yersinia pestis antigen fraction I in cells sensitive to animal plague].
    Aseeva LE; Mishan'kin MB; Goncharov EK; Shevchenko LA
    Biull Eksp Biol Med; 1995 Feb; 119(2):193-5. PubMed ID: 7670051
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and characterization of autotransporter proteins of Yersinia pestis KIM.
    Yen YT; Karkal A; Bhattacharya M; Fernandez RC; Stathopoulos C
    Mol Membr Biol; 2007; 24(1):28-40. PubMed ID: 17453411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
    Timofeeva LA; Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
    [No Abstract]   [Full Text] [Related]  

  • 12. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting the structure of LcrV from Yersinia pestis, a truly unique virulence protein.
    Nilles ML
    Structure; 2004 Mar; 12(3):357-8. PubMed ID: 15016350
    [No Abstract]   [Full Text] [Related]  

  • 14. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
    Khushiramani R; Tuteja U; Shukla J; Batra HV
    Indian J Exp Biol; 2004 May; 42(5):508-14. PubMed ID: 15233478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of virulence determinants unique to Yersinia pestis.
    Du Y; Galyov E; Forsberg A
    Contrib Microbiol Immunol; 1995; 13():321-4. PubMed ID: 8833863
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
    Weeks S; Hill J; Friedlander A; Welkos S
    Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmids of the pathogenicity of Yersinia pestis].
    Kutyrev VV; Popov IuA; Protsenko OA
    Mol Gen Mikrobiol Virusol; 1986 Jun; (6):3-11. PubMed ID: 3537763
    [No Abstract]   [Full Text] [Related]  

  • 20. A plague on host defense.
    Kopp E; Medzhitov R
    J Exp Med; 2002 Oct; 196(8):1009-12. PubMed ID: 12391011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.